Guobin He

5.0k total citations · 2 hit papers
25 papers, 4.0k citations indexed

About

Guobin He is a scholar working on Molecular Biology, Cancer Research and Pharmacology. According to data from OpenAlex, Guobin He has authored 25 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Pharmacology. Recurrent topics in Guobin He's work include Gastrointestinal motility and disorders (4 papers), Inflammatory mediators and NSAID effects (4 papers) and Cytokine Signaling Pathways and Interactions (4 papers). Guobin He is often cited by papers focused on Gastrointestinal motility and disorders (4 papers), Inflammatory mediators and NSAID effects (4 papers) and Cytokine Signaling Pathways and Interactions (4 papers). Guobin He collaborates with scholars based in United States, China and Japan. Guobin He's co-authors include Michael Karin, Guann‐Yi Yu, Syed R. Ali, Ryan G. Holzer, Eek Joong Park, Hiroyuki Takahashi, Jun Hee Lee, Christoph H. Österreicher, Toshiharu Sakurai and Susan M. Fischer and has published in prestigious journals such as Cell, Molecular Cell and Cancer Cell.

In The Last Decade

Guobin He

22 papers receiving 3.9k citations

Hit Papers

Dietary and Genetic Obesity Promote Liver Inflammation an... 2010 2026 2015 2020 2010 2010 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guobin He United States 15 1.7k 1.1k 1.1k 1.1k 811 25 4.0k
Tian Lan China 38 2.3k 1.3× 920 0.8× 587 0.5× 892 0.8× 630 0.8× 134 4.5k
Zili Zhang China 41 2.5k 1.4× 1.4k 1.2× 402 0.4× 1.2k 1.2× 736 0.9× 132 5.1k
Xiaoni Kong China 32 1.7k 1.0× 1.3k 1.1× 645 0.6× 515 0.5× 952 1.2× 114 4.4k
Paloma Martı́n-Sanz Spain 37 2.1k 1.2× 1.3k 1.1× 398 0.4× 885 0.8× 1.4k 1.7× 119 5.0k
Chin‐Wen Chi Taiwan 38 2.0k 1.2× 540 0.5× 559 0.5× 841 0.8× 381 0.5× 77 3.7k
Hironori Koga Japan 39 1.7k 1.0× 1.7k 1.5× 1.0k 0.9× 611 0.6× 441 0.5× 155 5.3k
Rui E. Castro Portugal 38 1.8k 1.1× 1.4k 1.2× 765 0.7× 882 0.8× 201 0.2× 83 3.8k
Bryan L. Copple United States 31 1.1k 0.6× 1.5k 1.3× 903 0.8× 473 0.4× 317 0.4× 59 3.5k
Yingqun Zhou China 37 1.4k 0.8× 919 0.8× 456 0.4× 615 0.6× 255 0.3× 92 3.3k
Atsushi Umemura Japan 27 1.6k 0.9× 1.9k 1.7× 349 0.3× 486 0.5× 463 0.6× 80 3.8k

Countries citing papers authored by Guobin He

Since Specialization
Citations

This map shows the geographic impact of Guobin He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guobin He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guobin He more than expected).

Fields of papers citing papers by Guobin He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guobin He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guobin He. The network helps show where Guobin He may publish in the future.

Co-authorship network of co-authors of Guobin He

This figure shows the co-authorship network connecting the top 25 collaborators of Guobin He. A scholar is included among the top collaborators of Guobin He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guobin He. Guobin He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Wang, Ping, et al.. (2023). Developing the modified 4-item version of perceived stress scale for functional dyspepsia. BMC Gastroenterology. 23(1). 97–97. 8 indexed citations
5.
Li, Qunhua, Guobin He, & Ming Wen. (2016). Effects of changing cognitive factors on the quality of life in patients with functional dyspepsia. Zhonghua xiaohua zazhi. 36(11). 758–762. 1 indexed citations
6.
He, Guobin, Debanjan Dhar, Hayato Nakagawa, et al.. (2013). Identification of Liver Cancer Progenitors Whose Malignant Progression Depends on Autocrine IL-6 Signaling. Cell. 155(2). 384–396. 358 indexed citations
7.
Kim, Youngsoo, Jeff Hsu, Tianyuan Zhou, et al.. (2013). Abstract LB-317: Potent in vivo pharmacology of AZD9150, a next-generation, constrained ethyl-modified antisense oligonucleotide targeting STAT3 in multiple preclinical cancer models.. Cancer Research. 73(8_Supplement). LB–317. 2 indexed citations
8.
Yu, Guann‐Yi, Guobin He, Chia‐Yang Li, et al.. (2012). Hepatic Expression of HCV RNA-Dependent RNA Polymerase Triggers Innate Immune Signaling and Cytokine Production. Molecular Cell. 48(2). 313–321. 49 indexed citations
9.
He, Guobin & Michael Karin. (2010). NF-κB and STAT3 – key players in liver inflammation and cancer. Cell Research. 21(1). 159–168. 946 indexed citations breakdown →
10.
He, Guobin, Guann‐Yi Yu, Vladislav Temkin, et al.. (2010). Hepatocyte IKKβ/NF-κB Inhibits Tumor Promotion and Progression by Preventing Oxidative Stress-Driven STAT3 Activation. Cancer Cell. 17(3). 286–297. 359 indexed citations
11.
Park, Eek Joong, Jun Hee Lee, Guann‐Yi Yu, et al.. (2010). Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression. Cell. 140(2). 197–208. 1352 indexed citations breakdown →
12.
Koch, Katherine S., Shin Maeda, Guobin He, Michael Karin, & Hyam L. Leffert. (2009). Targeted deletion of hepatocyte Ikkβ confers growth advantages. Biochemical and Biophysical Research Communications. 380(2). 349–354. 15 indexed citations
13.
Sakurai, Toshiharu, Guobin He, Atsushi Matsuzawa, et al.. (2008). Hepatocyte Necrosis Induced by Oxidative Stress and IL-1α Release Mediate Carcinogen-Induced Compensatory Proliferation and Liver Tumorigenesis. Cancer Cell. 14(2). 156–165. 408 indexed citations
14.
He, Guobin, et al.. (2007). The Microvacular Thrombi of Colonic Tissue in Ulcerative Colitis. Digestive Diseases and Sciences. 52(9). 2236–2240. 5 indexed citations
15.
He, Guobin, You Me Sung, John DiGiovanni, & Susan M. Fischer. (2006). Thiazolidinediones Inhibit Insulin-Like Growth Factor-I–Induced Activation of p70S6 Kinase and Suppress Insulin-Like Growth Factor-I Tumor-Promoting Activity. Cancer Research. 66(3). 1873–1878. 48 indexed citations
16.
He, Guobin, You Me Sung, & Susan M. Fischer. (2006). Troglitazone induction of COX-2 expression is dependent on ERK activation in keratinocytes. Prostaglandins Leukotrienes and Essential Fatty Acids. 74(3). 193–197. 10 indexed citations
17.
Sung, You Me, et al.. (2006). Overexpression of the prostaglandin E2 receptor EP2 results in enhanced skin tumor development. Oncogene. 25(40). 5507–5516. 58 indexed citations
18.
He, Guobin, Stephanie J. Muga, Philippe Thuillier, Ronald A. Lubet, & Susan M. Fischer. (2005). The effect of PPARγ ligands on UV‐ or chemically‐induced carcinogenesis in mouse skin. Molecular Carcinogenesis. 43(4). 198–206. 23 indexed citations
19.
He, Guobin, Philippe Thuillier, & Susan M. Fischer. (2004). Troglitazone Inhibits Cyclin D1 Expression and Cell Cycling Independently of PPARγ in Normal Mouse Skin Keratinocytes. Journal of Investigative Dermatology. 123(6). 1110–1119. 31 indexed citations
20.
He, Guobin, E.I.F. Pearce, & C.H. Sissons. (2002). Inhibitory effect of ZnCl2 on glycolysis in human oral microbes. Archives of Oral Biology. 47(2). 117–129. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026